Ib Jarle Christensen

University of Copenhagen

Papers

1

Total Citations

25

H-Index

1

About

Ib Jarle Christensen is a leading figure in urological oncology, with a primary research focus on functional and oncological outcomes following robot-assisted radical prostatectomy (RARP). His work is instrumental in understanding the complex trade-offs between cancer control and quality of life after surgery. Christensen’s major contribution lies in the systematic application and validation of the Survival, Continence, and Potency (SCP) system, a comprehensive framework for reporting post-prostatectomy results. His most cited paper, "Early biochemical recurrence, urinary continence and potency outcomes following robot-assisted radical prostatectomy" (2014, 25 citations), provides a landmark description of recovery trajectories for these key functional domains. This work has helped establish evidence-based benchmarks for surgical success, directly influencing clinical counseling and patient expectations. By rigorously documenting both oncological safety and functional recovery, Christensen has advanced the field’s understanding of how to optimize patient outcomes in the era of minimally invasive surgery, making his research essential reading for urologists and researchers dedicated to improving survivorship after prostate cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Early biochemical recurrence, urinary continence and potency outcomes following robot-assisted radical prostatectomy
25 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: University of Copenhagen

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago